Submission of intimation of trading window closure.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astal Laboratories Limited has informed BSE that the trading window for dealing in its securities will remain closed from October 1, 2025, until 48 hours after the declaration of its unaudited financial results for the quarter ended September 30, 2025. The closure applies to all Directors, Officers, Designated Persons, and their immediate relatives, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The date of the board meeting to consider and approve the Q2 FY26 financial results will be communicated separately. The intimation was signed by Mahendra Kumar, Company Secretary and Compliance Officer.
This is a routine regulatory compliance filing and not a material corporate event. No direct impact on shareholders or stock price is expected, though the upcoming Q2 results announcement will be the next significant catalyst for the stock.